دورية أكاديمية

1008PD - ZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antigen receptor T cell therapy in pediatric and adolescent patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL)

التفاصيل البيبلوغرافية
العنوان: 1008PD - ZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antigen receptor T cell therapy in pediatric and adolescent patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL)
المؤلفون: Lee, D.W., Wayne, A.S., Huynh, V., Handgretinger, R., Pieters, R., Michele, G., Baruchel, A., Feuchtinger, T., Bertrand, Y., Hemiston, M., Brown, P.A., Rossi, J., Jiang, Y., Navale, L., Stout, S., Aycock, J., Mardiros, A., Wiezorek, J., Jain, R.
المصدر: In Annals of Oncology September 2017 28 Supplement 5:v360-v361
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdx373.014